Back to Search
Start Over
Review Date For Shingle Vaccine Extended.
- Source :
- BioPharm International; Apr2006, Vol. 19 Issue 4, p20-20, 1/9p
- Publication Year :
- 2006
-
Abstract
- The article presents Merck's biologics license for Zostavax, an experimental shingles vaccine. The decision regarding whether or not to approve this license has been delayed by the Food and Drugs Administration. The goal for the new review date is set on May 25. The reason for the extension is for further review of additional information submitted by Merck.
Details
- Language :
- English
- ISSN :
- 1542166X
- Volume :
- 19
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- BioPharm International
- Publication Type :
- Periodical
- Accession number :
- 20440282